192 related articles for article (PubMed ID: 27129269)
1. Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.
Fancy RM; Wang L; Zeng Q; Wang H; Zhou T; Buchsbaum DJ; Song Y
J Biol Chem; 2016 Jun; 291(24):12862-12870. PubMed ID: 27129269
[TBL] [Abstract][Full Text] [Related]
2. Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.
Fancy RM; Kim H; Zhou T; Zinn KR; Buchsbaum DJ; Song Y
J Cell Biochem; 2017 Aug; 118(8):2285-2294. PubMed ID: 28092099
[TBL] [Abstract][Full Text] [Related]
3. Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study.
Yang H; Song Y
J Mol Model; 2016 Apr; 22(4):89. PubMed ID: 26995783
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.
Fancy RM; Kim H; Napier T; Buchsbaum DJ; Zinn KR; Song Y
J Cell Biochem; 2018 Jul; 119(7):6216-6230. PubMed ID: 29663486
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin binding to the Fas death domain. Regulation by Fas activation.
Ahn EY; Lim ST; Cook WJ; McDonald JM
J Biol Chem; 2004 Feb; 279(7):5661-6. PubMed ID: 14594800
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
[TBL] [Abstract][Full Text] [Related]
7. Characterization of calmodulin-Fas death domain interaction: an integrated experimental and computational study.
Fancy RM; Wang L; Napier T; Lin J; Jing G; Lucius AL; McDonald JM; Zhou T; Song Y
Biochemistry; 2014 Apr; 53(16):2680-8. PubMed ID: 24702583
[TBL] [Abstract][Full Text] [Related]
8. Identification of the Calmodulin-Binding Domains of Fas Death Receptor.
Chang BJ; Samal AB; Vlach J; Fernandez TF; Brooke D; Prevelige PE; Saad JS
PLoS One; 2016; 11(1):e0146493. PubMed ID: 26735300
[TBL] [Abstract][Full Text] [Related]
9. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
Jin TG; Kurakin A; Benhaga N; Abe K; Mohseni M; Sandra F; Song K; Kay BK; Khosravi-Far R
J Biol Chem; 2004 Dec; 279(53):55594-601. PubMed ID: 15485835
[TBL] [Abstract][Full Text] [Related]
10. Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis.
Das S; Tripathi N; Siddharth S; Nayak A; Nayak D; Sethy C; Bharatam PV; Kundu CN
Apoptosis; 2017 Oct; 22(10):1205-1224. PubMed ID: 28702823
[TBL] [Abstract][Full Text] [Related]
11. Conformation and free energy analyses of the complex of calcium-bound calmodulin and the Fas death domain.
Suever JD; Chen Y; McDonald JM; Song Y
Biophys J; 2008 Dec; 95(12):5913-21. PubMed ID: 18820240
[TBL] [Abstract][Full Text] [Related]
12. Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling.
McDonald ER; Chui PC; Martelli PF; Dicker DT; El-Deiry WS
J Biol Chem; 2001 May; 276(18):14939-45. PubMed ID: 11279061
[TBL] [Abstract][Full Text] [Related]
13. The intrinsically kinase-inactive EPHB6 receptor predisposes cancer cells to DR5-induced apoptosis by promoting mitochondrial fragmentation.
El Zawily AM; Toosi BM; Freywald T; Indukuri VV; Vizeacoumar FJ; Leary SC; Freywald A
Oncotarget; 2016 Nov; 7(47):77865-77877. PubMed ID: 27788485
[TBL] [Abstract][Full Text] [Related]
14. N-terminal and C-terminal domains of calmodulin mediate FADD and TRADD interaction.
Papoff G; Trivieri N; Marsilio S; Crielesi R; Lalli C; Castellani L; Balog EM; Ruberti G
PLoS One; 2015; 10(2):e0116251. PubMed ID: 25643035
[TBL] [Abstract][Full Text] [Related]
15. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5.
Adams C; Totpal K; Lawrence D; Marsters S; Pitti R; Yee S; Ross S; Deforge L; Koeppen H; Sagolla M; Compaan D; Lowman H; Hymowitz S; Ashkenazi A
Cell Death Differ; 2008 Apr; 15(4):751-61. PubMed ID: 18219321
[TBL] [Abstract][Full Text] [Related]
17. Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.
Fernandez TF; Samal AB; Bedwell GJ; Chen Y; Saad JS
J Biol Chem; 2013 Jul; 288(30):21898-908. PubMed ID: 23760276
[TBL] [Abstract][Full Text] [Related]
18. Structure of the complex of calmodulin with the target sequence of calmodulin-dependent protein kinase I: studies of the kinase activation mechanism.
Clapperton JA; Martin SR; Smerdon SJ; Gamblin SJ; Bayley PM
Biochemistry; 2002 Dec; 41(50):14669-79. PubMed ID: 12475216
[TBL] [Abstract][Full Text] [Related]
19. Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.
Chen Y; Pawar P; Pan G; Ma L; Liu H; McDonald JM
J Cell Biochem; 2008 Feb; 103(3):788-99. PubMed ID: 17654480
[TBL] [Abstract][Full Text] [Related]
20. DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design.
Tur V; van der Sloot AM; Reis CR; Szegezdi E; Cool RH; Samali A; Serrano L; Quax WJ
J Biol Chem; 2008 Jul; 283(29):20560-8. PubMed ID: 18474604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
